Journal of Nihon University Medical Association
Online ISSN : 1884-0779
Print ISSN : 0029-0424
ISSN-L : 0029-0424
Special Articles:
Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
Yoshihito Uchino
Author information
JOURNAL FREE ACCESS

2015 Volume 74 Issue 5 Pages 219-221

Details
Abstract

Autologous peripheral blood stem cell transplantation for multiple myeloma and the impact novel therapies after APBSCT improve survival. But upper limit of age who indicate APBSCT is under 65-year-old. Recently, tandem stem cell transplantation such as auto-allo, or double APBSCT are more improves outcome of patient with high risk. Also bortezomib and immunomodulatory drugs are powerful tool after transplantation maintenance therapy.

Content from these authors
© 2015 The Nihon University Medical Association
Previous article Next article
feedback
Top